美国儿童家长报告自闭症谱系障碍患病率
这些儿童比患其他情绪或行为障碍及无这些疾病的儿童有更多医疗需求和就医困难。目前患ASD的儿童中27%使用药物治疗ASD相关症状,64%在过去12个月接受行为治疗,治疗使用率随社会人口学特征和共病情况而异。
要点
- 2016年NSCH估计美国3-17岁儿童家长报告ASD现患率约2.50%(每40名儿童中1名)。
- ASD儿童比患其他情绪行为障碍及无这些疾病的儿童有更多医疗需求和就医困难。
- 现患ASD儿童中27%用药治疗ASD相关症状,64%近12个月接受行为治疗。
核心结论
- ASD儿童医疗需求更高且就医困难更多,治疗使用率随社会人口学特征和共病情况变化。
研究设计与样本
- 通过家长报告收集儿童是否曾获照护者ASD诊断、目前ASD状态、卫生保健使用、可及性与挑战及治疗方法。
主要发现
- 家长报告ASD诊断的儿童比患其他情绪或行为障碍(如注意缺陷多动障碍、焦虑、行为或品行问题、抑郁、发育迟缓、唐氏综合征、智力障碍、学习障碍、抽动秽语综合征)及无这些疾病的儿童更可能有更高医疗需求和就医困难。
- 目前患ASD的儿童中,27%正使用药物治疗ASD相关症状,64%在过去12个月接受行为治疗,使用率随社会人口学特征和共病情况而异。
关键数值与推荐
- 目前患ASD儿童中27%使用药物治疗ASD相关症状,64%在过去12个月接受行为治疗。
临床怎么用
- 儿科医生应了解家长报告ASD的儿童医疗需求更高且就医困难更多,需关注其卫生保健可及性。
- 评估ASD儿童治疗时需考虑药物治疗(27%)和行为治疗(64%)的使用情况,并注意社会人口学特征和共病的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: : media-1vid110.1542/5839990273001PEDS-VA_2017-4161Video Abstract OBJECTIVES: To estimate the national prevalence of parent-reported autism spectrum disorder (ASD) diagnosis among US children aged 3 to 17 years as well as their treatment and health care experiences using the 2016 National Survey of Children's Health (NSCH). METHODS: The 2016 NSCH is a nationally representative survey of 50 212 children focused on the health and well-being of children aged 0 to 17 years. The NSCH collected parent-reported information on whether children ever received an ASD diagnosis by a care provider, current ASD status, health care use, access and challenges, and methods of treatment. We calculated weighted prevalence estimates of ASD, compared health care experiences of children with ASD to other children, and examined factors associated with increased likelihood of medication and behavioral treatment. RESULTS: Parents of an estimated 1.5 million US children aged 3 to 17 years (2.50%) reported that their child had ever received an ASD diagnosis and currently had the condition. Children with parent-reported ASD diagnosis were more likely to have greater health care needs and difficulties accessing health care than children with other emotional or behavioral disorders (attention-deficit/hyperactivity disorder, anxiety, behavioral or conduct problems, depression, developmental delay, Down syndrome, intellectual disability, learning disability, Tourette syndrome) and children without these conditions. Of children with current ASD, 27% were taking medication for ASD-related symptoms, whereas 64% received behavioral treatments in the last 12 months, with variations by sociodemographic characteristics and co-occurring conditions. CONCLUSIONS: The estimated prevalence of US children with a parent-reported ASD diagnosis is now 1 in 40, with rates of ASD-specific treatment usage varying by children's sociodemographic and co-occurring conditions.
引用
- Kogan MD, Vladutiu CJ, Schieve LA, et al. The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children. Pediatrics. 2018. PMID: 30478241. doi:10.1542/peds.2017-4161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。